Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sarah El Mershati"'
Autor:
Sarah El Mershati, Sixtine De Percin, François Goldwasser, Rui Batista, Audrey Thomas-Schoemann, Pascaline Boudou-Rouquette, Clémentine Villeminey, Anthia Monribot, Anne Catherine Piketty, Benoit Blanchet, David Balakirouchenane, Ithar Gataa, Jérôme Alexandre, Anne Jouinot, Audrey Bellesoeur, Michel Vidal, Camille Tlemsani
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:741-751
The risk of drug–drug interactions (DDI) has become a major issue in cancer patients. However, data in sarcoma patients are scarce. We aimed to evaluate the frequency and the factors associated with DDI with antitumor treatments, and to evaluate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf068fc574619aaa3b023f90db4f0db0
https://doi.org/10.1007/s00280-021-04311-4
https://doi.org/10.1007/s00280-021-04311-4
Autor:
Audrey Bellesoeur, Ithar Gataa, Anne Jouinot, Sarah El Mershati, Anne Catherine Piketty, Camille Tlemsani, David Balakirouchenane, Anthia Monribot, Michel Vidal, Rui Batista, Sixtine De Percin, Clementine Villeminey, Jerome Alexandre, Francois Goldwasser, Benoit Blanchet, pascaline Boudou-Rouquette, Audrey Thomas-Schoemann
Publikováno v:
Cancer chemotherapy and pharmacology. 88(4)
Background: The risk of drug drug interactions (DDI) has become a major issue in cancer patient care. However, data in sarcoma patients are scarce. We aimed to evaluate the frequency of DDI with antitumor treatments, identify the risk factors for DDI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abe2f4f20f3d54b0f969b7b05187f7e5
https://pubmed.ncbi.nlm.nih.gov/34304283
https://pubmed.ncbi.nlm.nih.gov/34304283
Autor:
Salvatore Cisternino, Agathe Thouvenin, Caroline Tuchmann-Durand, Pascale de Lonlay, Sarah El Mershati, Philippe-Henri Secrétan, Joël Schlatter
Publikováno v:
Pharmaceutical Development and Technology
Hydroxychloroquine is an antimalarial drug indicated in the treatment of acute attacks of malaria due to Plasmodium vivax, P. malariae, P. ovale, and susceptible strains of P. falciparum. It is also used for the treatment of rheumatoid arthritis, dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::088ef1a743b84f42cfde7661f2a62d76
https://pubmed.ncbi.nlm.nih.gov/33428504
https://pubmed.ncbi.nlm.nih.gov/33428504